Replies to post #317876 on Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

Aesop's Fables "The Boy Who Cried Wolf" strategy

Just watched an interesting movie that is reminiscent of your thoughts. Which PR will be the PR that takes IPIX up for good

Great PR after great PR yet the stock only seems to tread water. Why is that? The pessimists have a field day taunting anyone willing to risk a long wager here. Flippers brag about their .02 gains. Eventually the trading range will break, but which direction?

What happens if there is another great PR and the stock goes down? Who will question the company even greater and doubt anything real will come out of Brilacidin for Covid19?

Fortunately what is happening in the stock market in general should propel us higher than previously thought "if and when" IPIX breaks to the upside. If any of you were playing the OTC back in the late 90's when Nasdaq was approaching it's highs, you will know what I mean.

IMHO filling in all the holes to the story since February should do the trick when IPIX submits it's app to the FDA for human trials.

[cybermich]

Hey petemantx..good post
I see the peer reviews as being more important to the "decision makers" (including the FDA, those handing out Grants, BP etc.)
I don't think it will be the peer reviews per se that catapults the share price but imo it will be one of the reasons we eventually get the big news that does:)

[MinnieM]

The data that comes out of those two US RBL's and the one prepring of the peer reviewed article is what will help the FDA approve the upcoming trial against covid.

That same data will up the chances of a good grant to the company moving forward.

The timing of all this should come about the same time as IV drug is manufactured.

The only grant I expect to see near term is that applied for by one of the RBL's for more extensive testing of Brilacidin against a variety of different viruses.

I expect a good move with trial start since most don't expect it to happen.







Message in reply to:

Is the next PR reporting the latest RBL data the straw that breaks the camel's back as to getting Brilacidin in the spotlight of media and governmental attention (as say perhaps a mention that it the only TRUE treatment "cure" coming down the pike)? I would like to think so but to date hasn't worked out that way.

I still firmly believe we need some serious grant money from some source for the general public/world of medicine/etc to take IPIX seriously and finally get the science of Brilacidin known to the general public.

Now coupling such a nice sized grant with RBL data to show this is about the first such grant going to a truly deserving drug, and not one foisted on the public to pay off lobbying payola, that both kills CV19 prior to infection and after being infected to a startlingly effective degree, that would get the attention of America IMO.

At this point in time, the peer review article is just so much noise as by the time it gets disseminated Brilacidin will already be in a human trial and actual patient results will top professional opinion IMO.